Opioid Addiction Identification and Medication for Opioid Use Disorder (MOUD)
Overview:
The "Opioid Addiction Identification and Medication for Opioid Use Disorder (MOUD)" course is an educational program designed to equip healthcare professionals with the knowledge and skills necessary to effectively address the opioid crisis. Led by an expert in addiction medicine, participants will explore key topics such as the definition and scope of opioid addiction, the neurobiology of addiction, risk factors for opioid addiction, and common signs and symptoms of opioid use disorder. Emphasis is placed on the importance of early screening and comprehensive assessment techniques to identify patients with opioid addiction in clinical practice. Interactive case studies and scenarios provide opportunities for participants to apply their knowledge in real-world clinical situations, while resources and support systems are highlighted to facilitate ongoing learning and professional development in this critical area of healthcare
Target Audience
This course is designed for physicians, physician assistants, nurse practitioners, registered nurses, social workers, pharmacists, dentists, medical students and residents, and healthcare administrators.
Learning Objectives
By the end of this course, the learner will be able to:
1. Describe effective screening and assessment techniques for identifying patients with opioid use disorder in clinical practice.
2. Explain the principles and goals of Medication for Opioid Use Disorder (MOUD), including the use of FDA-approved medications and their mechanisms of action.
3. Implement patient engagement strategies and counseling techniques to enhance adherence to MOUD and address stigma and barriers to treatment.
4. Analyze case studies and interactive scenarios to apply knowledge of opioid addiction identification and MOUD principles to real-world clinical situations.
Edwin C Chapman, MD
Addiction & Internal Medicine
Dr. Edwin C. Chapman has practiced in Washington, DC for over 47 years specializing in Internal Medicine and Addiction Medicine. Over the past 21 years, he has investigated the complex mix of addiction, undertreated mental illness, infectious diseases (AIDS & Hepatitis C), criminal behavior, and chronic diseases in which patients have 20-25 year shorter life expectancies. Dr. Chapman received his B.S. in 1969 and M.D. in 1973 from Howard University College of Medicine. He completed his internship and residency in internal medicine as well as a fellowship in cardiology from historic Freedmen’s and Howard University Hospitals. He is board certified by the American Board of Internal Medicine (ABIM, 1979), the American Society of Addiction Medicine (ASAM grandfathered to ABAM, 2009), a Fellow of the American Society of Addiction Medicine, and a member of Alpha Omega Alpha Honor Medical Society. He maintains active memberships in the National Medical Association (NMA), Medico Chirurgical Society of Washington, DC (MED CHI of DC), the American Medical Association (AMA), the Medical Society of the District of Columbia (MSDC) as well as associate membership in the Black Psychiatrists of America.
Dr. Chapman is a founding member and secretary of the board of directors of the Leadership Council for Healthy Communities (an inter-faith 501(c)3 organization with 30+ Metro DC institutions) where he is bringing integrated medical care into underserved communities and faith institutions (ACA’s “Accountable Health Community”) using both onsite care and virtual care thru tele-video consultation for social work, nutritional consulting, pharmaceutical reconciliation, as well as psychiatry and primary care. Using this urban, collaborative care virtual office telemedicine design, he is addressing the needs of opioid-addicted index patients and their entire families recognizing the impact of addiction as a “social determinant of health” and a factor leading to “toxic stress” in both family and community-wide settings. In 2008, Dr. Chapman was featured in the National Alcohol and Drug Addiction Month DVD entitled “Medication-Assisted Therapies: Providing a Whole-Patient Approach to Treatment” sponsored and produced by the Substance Abuse and Mental Health Services Administration (SAMHSA). He was appointed in January 2019 to the National Academy of Science Engineering and Medicine committee “Examination of the Integration of Opioid and Infectious Diseases Prevention Efforts in Select Programs” and currently collaborates on research protocols with the Howard University School of Pharmacy and College of Medicine.
Dr. Chapman is a widely sought speaker on the impact of historical oppression and anxiety/depression reactive addiction on the African American community and has been featured in The Washington Post, Addiction Professional Magazine, HIT Consultant.com, NPR, EBONY MAGAZINE, Washington WUSA 9, Behavioral Healthcare Magazine, PBS News Hour, The HILL, Canadian Broadcasting Corporation, and international Spanish TV. He was recognized by the National Medical Association as their 2016 “Practitioner of the Year,” Prince George’s County Links, Inc 40th Anniversary 1st awardee for “Excellence in Health and Human Services,” and the Black Mental Health Alliance for Education and Counseling “2019 Phoenix Arising Behavioral Health Provider of the Year Award.”
Clinical Advisors
Careen-Joan Franklin, PharmD
Clinical Assistant Professor at Howard University College of Pharmacy
Conflicts of Interest
The instructor, advisor, and planners of the course have no conflicts of interest to declare.
Anti-discrimination Policy
Dr. Chapman, the course advisor, and the course planners have agreed to our anti-discrimination policy that prohibits the inclusion of discriminatory language, graphics, or references on the basis of race, gender identity, age, color, national origin, physical or mental disability, or religion.
PHARMACISTS AND PHARMACY TECHNICIANS
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE Pharmacist: (1.5 Contact Hour) UAN: 0536-9999-24-008-H08-P
ACPE Pharmacy Technician: (1.5 Contact Hour) UAN: 0536-9999-24-008-H08-T
PHYSICIANS – AMA CREDIT DESIGNATION STATEMENT
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA PRA Category 1 Credit™
PHYSICIANS – ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The George Washington University School of Medicine and Health Sciences and Innovation Horizons. The George Washington University School of Medicine and Health Sciences is accredited by the ACCME to provide continuing medical education for physicians.
Available Credit
- 1.50 ACPE PharmacistThe George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.50 ACPE Pharmacy technicianThe George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.50 AMA PRA Category 1 Credit™The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 1.50 Completion
Required Hardware/software
High-Speed Internet Connection
Adobe Reader for PDF file download
Browser
Please avoid using popup blockers for this course!
This educational activity has been tested in the latest versions of Edge, Firefox, Safari, and Chrome browsers on Windows or Macintosh computers.
The Safari, Firefox, or Chrome browsers are recommended for best results.
The Internet Explorer browser is not recommended as it is no longer supported by Microsoft.